Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

INTRODUCTION: Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Lewy bodie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Dement (Amst)
Hlavní autoři: Janssens, Jana, Vermeiren, Yannick, Fransen, Erik, Aerts, Tony, Van Dam, Debby, Engelborghs, Sebastiaan, De Deyn, Peter P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2018
Témata:
Blood-Based Biomarkers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852321/
https://ncbi.nlm.nih.gov/pubmed/29552632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.01.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky